FDA Rescinds Approval of Avastin for Breast Cancer
November 21st 2011In an expected move, the FDA has withdrawn its accelerated approval of Avastin (bevacizumab) for the treatment of breast cancer. Specifically, bevacizumab is no longer indicated for use in combination with paclitaxel for patients with HER2-negative metastatic breast cancer who have not undergone chemotherapy.
Genital Wart Management: A Partnership Between Physician and Patient
With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System
And my task for this afternoon is to review for you a new contraceptive option and what I’d like to do first is show you my disclosure statement and then I will go into the first part of discussion, talk about why I think there’s a need for this new contraception option and then go in much greater depth in discussing it.
Transdermal Contraception: Contraception Patch. Interview with Ronald T. Burkman, MD
“We just heard a presentation about one of the several new devices for contraception and you took part in a lot of research about this Transdermal Patches for contraception.
Romeo's Bleeding: "When Mr. Right Turns Out To Be Mr. Wrong"
November 15th 2011As we move along through this series of articles, try not be intimidated by "clinical" terms, such as 'personality disorder,' 'borderline,' 'sociopath,' etc. They are just words professionals have come to use in describing different technical aspects of mind and personality.
New Warnings about Perinatal Antidepressant Exposure
November 15th 2011Studies have shown that it is important for both the mother’s and the fetus’ well-being to treat maternal depression. As such, the use of antidepressants during pregnancy has increased. However, new research now shows that treatment with certain antidepressants just before and just after delivery may actually have a negative impact on the baby’s brain circuitry.